- Associated Press•21 hours ago
The Austin, Texas-based company said it had net income of 13 cents per share. The manufacturer of testing systems for biotechnology companies posted revenue of $64.2 million in the period. Luminex expects ...
- Benzinga•23 days ago
Luminex Corporation (NASDAQ: LMNX ) received FDA approval, as well as CE-IVD marking for a fresh in vitro diagnostic system, the ARIES M1 System. According to the company, it was meant for lower throughput ...
|Bid||21.33 x 100|
|Ask||21.34 x 300|
|52wk Range||16.16 - 23.75|
|Day's Range||21.14 - 23.75|
|Avg Vol (3m)||226,223|
As of 4:00 PM EDT. Market closed.